In this week’s patent news: Patent Office notifies Supreme Court’s order on Extensions of Timelines; Patent office announces JPO/IPR Training Course FY 2021; BananaIP and NASSCOM to organize a Master Class on IP; Panacea Biotec accuses Sanofi of patent infringement, files suit; Natco and Eli Lilly sign patent license agreement for production of Barcitinib; NATCO and Eli Lilly sign patent license agreement for production of Barcitinib; India and South Africa propose three-year patent waiver.
Patent Office notifies Supreme Court’s…
In this week’s Patent & Design News - “Innovate, Patent, Produce and Prosper,” says PM Narendra Modi; 12th edition of GIPC to be held in New Delhi, this week; IPO issues notification containing list of withdrawn patent applications; Taiho Pharmaceutical files patent infringement lawsuit against Natco Pharma; Eli Lilly wins lawsuit instituted against Apotex Inc. and other news updates.
India Patent News
12th edition of GIPC to be held in New Delhi, this week
The 12th edition of the…
“You win some and you lose some”, this is a phrase all too familiar to most people and more specifically to the market of pharmaceuticals. It is perhaps this phrase that most pharmaceutical companies live by during their existence! Patent infringement, claim invalidation, compulsory license and Generic companies are the most clichéd words that one comes across, whenever there is a mention of pharmaceutical patents. Eli Lilly (a cancer treatment drug) happens to be one such entity that has “been…